T1000	Speculation 415 422	suggest
E1000	Speculation:T1000 Scope:T1001
T1001	Span 415 495	suggest that deregulation of BCL-6 expression may contribute to DLCL development
T1002	Negation 187 189	no
E1001	Negation:T1002 Scope:T1003
T1003	Span 187 255	no proof yet exists of a role for these lesions in DLCL pathogenesis
T1004	Negation 703 710	lacking
E1002	Negation:T1004 Scope:T1005
T1005	Span 703 725	lacking BCL-6 function
T1006	Speculation 461 464	may
E1003	Speculation:T1006 Scope:T1007
T1007	Span 461 495	may contribute to DLCL development
T1008	Speculation 1191 1199	suggests
E1004	Speculation:T1008 Scope:T1009
T1009	Span 1191 1326	suggests that these lesions may be useful as markers in selection of differential therapeutic strategies based on different risk groups
T1010	Speculation 860 863	may
E1005	Speculation:T1010 Scope:T1011
T1011	Span 860 899	may have relevant clinical implications
T1012	Speculation 1557 1560	may
E1006	Speculation:T1012 Scope:T1013
T1013	Span 1557 1668	may serve as critical tools for sensitive monitoring of minimal residual disease and early diagnosis of relapse
T1014	Speculation 1219 1222	may
E1007	Speculation:T1014 Scope:T1015
T1015	Span 1219 1326	may be useful as markers in selection of differential therapeutic strategies based on different risk groups
